II. Criteria
- Asymptomatic on most days without interference with normal activity
- Occasional exacerbations (Less than twice/week)
- Exacerbations are brief (hours to days)
- Nighttime exacerbations are 2 or less times monthly
- Short-acting Beta Agonist (e.g. Albuterol) use 2 or less times weekly
- Oral Corticosteroids required 0-1 times per year
- Normal Pulmonary Function Test between exacerbations
- FEV1 or PEF >80% predicted
- FEV1 to FVC Ratio normal (>85% for age 5-19 years, >80% for age 20-39 years, >75% for age 40-59, then >70%)
- PEF Variability <20%
III. Management
- See Asthma Stepped Care
- No daily medications necessary
- Inhaled short acting Beta Agonist as needed
- If beta Agonist use more than twice per week:
- Step-up to Mild Persistent Asthma Management
- Consider long-term control (Inhaled Corticosteroids)
- Asthma Education
- Exacerbations
IV. Prevention
- See Asthma Education
- Influenza Vaccine
- Weight loss in Obesity
- Exercise
V. References
- Park (2017) Asthma Updates, Mayo Clinical Reviews, Rochester, MN
- (1997) Management of Asthma, NIH 97-4053
- (1995) Global Strategy for Asthma, NIH 95-3659
- Kalister (2001) West J Med 174:415-20 [PubMed]
- Kemp (2001) Am Fam Physician 63(7):1341-54 [PubMed]